This Week
The Developments
Litigation
Federal judge blocks Medicaid rule requiring medically frail enrollees to prove frailty to keep coverage
Ruling reported Oct. 29, 2026 (AP); further coverage Oct. 30
What changed
A federal judge blocked a Medicaid rule that would have forced medically frail Medicaid enrollees to prove their frailty to keep coverage under the work-requirement rules. According to AP coverage, the court left some other provisions in place, including a 12-month documentation limit and one self-attestation, while blocking the frailty-proof requirement. Reporting does not state the scope of relief (nationwide or limited to plaintiff states), and the case name and court order were not reviewed for this briefing.
Why it matters
Medically frail enrollees are among the people most likely to lose Medicaid coverage under work requirements. How the exemption is applied determines whether those with serious conditions keep coverage or must document their disability to retain it. Sources for this item are news reports, not the court order.
Warrants deeper follow-up. Obtain the court order to confirm the case name, the scope of relief, and whether states will appeal.
Sources
Background from our research
Storylines
Proposed
CMS proposes pre-eligibility verification for ACA exchange subsidies, starting in 2028
Proposed rule (CMS-9873-P) released Oct. 23, 2026; published in the Federal Register Oct. 27 (91 Fed. Reg. 67656); comments due Nov. 27, 2026
What changed
CMS proposed a rule, CMS-9873-P, that would require verification of eligibility before exchange enrollees receive advance premium tax credits, implementing a 2026 law aimed at exchange fraud. The proposal is for plan year 2028. CMS presents it as protecting taxpayers. The impact analysis was not available for this briefing, so this item reports no enrollment or premium estimates.
Why it matters
Pre-enrollment checks could reduce improper subsidy payments, and the rule would also add a verification step that some eligible people could fail to clear. The rule's own cost and enrollment estimates will determine how large that effect is, and they are not yet confirmed here. Comments close Nov. 27.
Warrants deeper follow-up. Read the Regulatory Impact Analysis in the proposed rule and add its enrollment and premium estimates, if confirmed.
Sources
Background from our research
Storylines
Litigation
CVS/Aetna and Centene sue CMS over 2027 Medicare Advantage Star Ratings
Centene filing reported about Oct. 22, 2026; CVS/Aetna complaint reported late October 2026
What changed
CVS/Aetna and Centene each filed suits challenging how CMS calculated their 2027 Medicare Advantage Star Ratings. CVS says the ratings cost it 43 contracts and about $2 billion in bonus revenue, figures the item attributes to CVS and does not verify. Separately, CMS appealed a court ruling in Clover Health's favor, a case about the same rating framework, with the appeal reported on July 21, 2026. The complaints were not reviewed directly; the reporting is from trade press.
Why it matters
Star Ratings set the quality bonus payments that Medicare Advantage plans receive, so disputes over the formula affect plan revenue and the benefits and premiums that follow. Multiple insurers suing at once signals that the 2027 ratings framework is contested in court.
Warrants deeper follow-up. Check the complaints and dockets; confirm the Clover appeal details with the court record.
Sources
Background from our research
Storylines
Report
KFF outlines what to watch in the 2027 ACA open enrollment period
Reported as open enrollment began, Nov. 1, 2026
What changed
KFF's analysis of the 2027 ACA open enrollment period lists the developments to watch as enrollment opens. As of Oct. 29, KFF counted 11 insurer exits and 7 entries in the marketplaces for 2027, a count that differs from the 'roughly a dozen' exits cited in earlier briefings because of timing. The analysis is a single source and was not cross-checked against CMS or CBO.
Why it matters
Insurer exits and entries determine how many plans and counties enrollees can choose from, which shapes both premiums and access to coverage during open enrollment.
Sources
Background from our research
Storylines
Administrative action
CMS ends the Part D premium stabilization demonstration, and some 2027 drug plan premiums will rise
Reported late October 2026; KFF analysis and trade press
What changed
CMS is ending the temporary Part D Premium Stabilization Demonstration that had subsidized stand-alone prescription drug plans. KFF projects that many enrollees will see modest premium increases for 2027, while others could pay much more if they do not switch plans. This briefing did not find CMS's own announcement or its stated rationale, so the reasons are as reported by KFF.
Why it matters
Stand-alone Part D enrollees who stay in their current plan may face higher premiums, and the people most exposed are those who do not compare plans during open enrollment.
Warrants deeper follow-up. Locate CMS's own announcement ending the demonstration and confirm its stated rationale.
Sources
Background from our research
Storylines